BCA
HQL

Bay Colony Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Bay Colony Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,530
Closed -$29K – 490
2018
Q2 		$29K Buy
+1,530
New +$28.8K 0.02% 454

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Bay Colony Advisors's HQL Position: Q3 2018 in Review

Bay Colony Advisors sold out of abrdn Life Sciences Investors (HQL) in Q3 2018, closing a stake of 1,530 shares — an estimated $29K sold.

Bay Colony Advisors first reported a position in HQL in Q2 2018 and held it in 1 quarter. The position peaked at $29K in Q2 2018. 57 funds tracked by Wall St. Rank hold HQL as of Q3 2018.

  • Bay Colony Advisors reported no remaining abrdn Life Sciences Investors position as of Q3 2018 after selling out during the quarter.
  • Bay Colony Advisors sold 1,530 abrdn Life Sciences Investors shares in Q3 2018, an estimated $29K.
  • Bay Colony Advisors first reported a position in abrdn Life Sciences Investors in Q2 2018 and held it in 1 quarter.
  • Bay Colony Advisors's abrdn Life Sciences Investors position peaked at $29K in Q2 2018.
  • 57 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.